{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigc5l5aoafkprcrzwjdqvsti64vrgsuarmbnnglkzbp3ajm4efeoq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3modqdbxtt6g2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib6bavqmt7z6plffngz6aug4j43gtm22e4iumtipif4wthefrr3mm"
    },
    "mimeType": "image/jpeg",
    "size": 197170
  },
  "path": "/2026/06/15/biotech-news-lilly-ajax-acquisition-may-have-been-worth-it/?utm_campaign=rss",
  "publishedAt": "2026-06-15T13:36:34.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "A syphilis drug shortage, Sanofi's diabetes drug approval, and more biotech news from The Readout",
  "title": "STAT+: Lilly’s Ajax acquisition may have been worth it",
  "updatedAt": "2026-06-15T13:36:39.000Z"
}